NNNN · Anbio Biotechnology
Market Cap
$316.89M
Shares
43.89M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$8.65M
+5.6%
FY2025
Net Income
$6.4M
+169.9%
FY2025
Gross Margin
87.24%
+15.3pp
FY2025
Operating Margin
66.7%
+42.3pp
FY2025
Diluted EPS
$0.15
+162.5%
FY2025
Operating Cash Flow
-$6.74M
-423.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| $8.65M | $8.19M | $6.71M | $23.54M | |
| $1.1M | $2.3M | $3.35M | $10.98M | |
| $7.54M | $5.89M | $3.36M | $12.56M | |
| 87.24% | 71.9% | 50.07% | 53.36% | |
| $201.31K | $454.23K | $134.7K | $200K | |
| $1.57M | $3.44M | $1.27M | $2.17M | |
| $1.78M | $3.89M | $1.4M | $2.37M | |
| $5.77M | $2M | $1.96M | $10.2M | |
| 66.7% | 24.38% | 29.22% | 43.3% | |
| — | — | — | $7999 | |
| $142.02K | $337.51K | $165.34K | $42.25K | |
| $635.72K | $377.48K | $292.78K | -$184.41K | |
| $6.4M | $2.37M | $2.25M | $10.01M | |
| $0 | $0 | $0 | — | |
| $6.4M | $2.37M | $2.25M | $10.01M | |
| 74.06% | 28.99% | 33.58% | 42.52% | |
| USD/shares | $0.15 | $0.06 | $0.11 | $100,112.00 |
| USD/shares | $0.15 | $0.06 | $0.11 | $100,112.00 |
| shares | 43.67M | 42.29M | 21.44M | 100 |
| shares | 43.67M | 42.29M | 21.44M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| European Union | $5,151,103 | $5,618,002 | $4,660,608 | $20,302,433 |
| Asia Pacific | $1,520,409 | $509,168 | $73,395 | $3,192,219 |
| Other Regions | $1,409,595 | $472,380 | $111,050 | — |
| North America | $296,199 | $110,508 | $215,437 | $50,000 |
| South America | $269,538 | $1,475,088 | $1,651,500 | — |
Key facts
CIK
1982708
CUSIP
G0367B105
13F (30d)
10 filings
10 filers
Visit website
Investor relations